Package 67184-0535-1

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 67184-0535-1
Digits Only 6718405351
Product NDC 67184-0535
Product ID 67184-0535_0afb3dc7-6072-4a53-acc4-59589fb8491e
Description

1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2021-04-12
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Decitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "0afb3dc7-6072-4a53-acc4-59589fb8491e", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0367184053513"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["5b2dce6f-c715-47dc-971e-06244ccd7548"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (67184-0535-1)  / 20 mL in 1 VIAL", "package_ndc": "67184-0535-1", "marketing_start_date": "20210412"}], "brand_name": "Decitabine", "product_id": "67184-0535_0afb3dc7-6072-4a53-acc4-59589fb8491e", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "67184-0535", "generic_name": "decitabine", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/20mL"}], "application_number": "ANDA212826", "marketing_category": "ANDA", "marketing_start_date": "20210412", "listing_expiration_date": "20261231"}